These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
153 related articles for article (PubMed ID: 37161915)
1. Utility of modified Glasgow prognostic score for head and neck squamous cell carcinoma: Systematic review and meta-analysis. Luan CW; Kuo LT; Wang YT; Liao CT; Kang CJ; Lee YC; Chen KY; Lai CH; Tsai YH; Huang EI; Tsai MS; Hsu CM; Chang GH; Tsai YT Head Neck; 2023 Jul; 45(7):1856-1867. PubMed ID: 37161915 [TBL] [Abstract][Full Text] [Related]
2. A comprehensive analysis of Glasgow Prognostic Score (GPS)/the modified Glasgow Prognostic Score (mGPS) on immune checkpoint inhibitor efficacy among patients with advanced cancer. Zhang Y; Chen S; Chen H; Li W Cancer Med; 2023 Jan; 12(1):38-48. PubMed ID: 35702873 [TBL] [Abstract][Full Text] [Related]
3. Utility of High-Sensitivity Modified Glasgow Prognostic Score in Cancer Prognosis: A Systemic Review and Meta-Analysis. Wu TH; Tsai YT; Chen KY; Yap WK; Luan CW Int J Mol Sci; 2023 Jan; 24(2):. PubMed ID: 36674837 [TBL] [Abstract][Full Text] [Related]
4. Prognostic Utility of the Modified Glasgow Prognostic Score in Urothelial Carcinoma: Outcomes from a Pooled Analysis. Tan D; Li J; Lin T; Tan P; Zhang J; Xiong Q; Jiang J; Li Y; Zhang P; Wei Q J Clin Med; 2022 Oct; 11(21):. PubMed ID: 36362488 [TBL] [Abstract][Full Text] [Related]
5. Squamous cell carcinoma antigen as a prognostic marker and its correlation with clinicopathological features in head and neck squamous cell carcinoma: Systematic review and meta-analysis. Travassos DC; Fernandes D; Massucato EMS; Navarro CM; Bufalino A J Oral Pathol Med; 2018 Jan; 47(1):3-10. PubMed ID: 28600896 [TBL] [Abstract][Full Text] [Related]
6. Predicting the treatment outcome of nivolumab in recurrent or metastatic head and neck squamous cell carcinoma: prognostic value of combined performance status and modified Glasgow prognostic score. Ueki Y; Takahashi T; Ota H; Shodo R; Yamazaki K; Horii A Eur Arch Otorhinolaryngol; 2020 Aug; 277(8):2341-2347. PubMed ID: 32239313 [TBL] [Abstract][Full Text] [Related]
7. A high Glasgow prognostic score (GPS) or modified Glasgow prognostic score (mGPS) predicts poor prognosis in gynecologic cancers: a systematic review and meta-analysis. Nie D; Zhang L; Wang C; Guo Q; Mao X Arch Gynecol Obstet; 2020 Jun; 301(6):1543-1551. PubMed ID: 32409927 [TBL] [Abstract][Full Text] [Related]
8. Pre-treatment Glasgow prognostic score and modified Glasgow prognostic score may be potential prognostic biomarkers in urological cancers: a systematic review and meta-analysis. Qi F; Xu Y; Zheng Y; Li X; Gao Y Ann Transl Med; 2019 Oct; 7(20):531. PubMed ID: 31807513 [TBL] [Abstract][Full Text] [Related]
9. Immune-modified Glasgow prognostic score: A new prognostic marker for head and neck cancer. Terazawa K; Ohashi T; Shibata H; Ishihara T; Ogawa T Head Neck; 2022 Nov; 44(11):2555-2563. PubMed ID: 36054630 [TBL] [Abstract][Full Text] [Related]
10. The prognostic role of PD-L1 expression for survival in head and neck squamous cell carcinoma: A systematic review and meta-analysis. Yang WF; Wong MCM; Thomson PJ; Li KY; Su YX Oral Oncol; 2018 Nov; 86():81-90. PubMed ID: 30409325 [TBL] [Abstract][Full Text] [Related]
11. Prognostic Significance of the Modified Glasgow Prognostic Score in Patients With Pancreatic Cancer: A Meta-Analysis. Fu W; Wang K; Yan S; Wang X; Tang B; Chang J; Wang R; Wu T Dose Response; 2020; 18(3):1559325820942065. PubMed ID: 32821253 [TBL] [Abstract][Full Text] [Related]
12. The preoperative sensitive-modified Glasgow prognostic score is superior to the modified Glasgow prognostic score in predicting long-term survival for esophageal squamous cell carcinoma. Tian R; Zhang F; Sun P; Wu J; Yan H; Wu AR; Zhang M; Jiang YL; Lu YH; Xu QY; Zhan XH; Zhang RX; Qian LT; He J Oncotarget; 2016 Oct; 7(41):67485-67494. PubMed ID: 27528228 [TBL] [Abstract][Full Text] [Related]
13. Prognostic value of pretreatment modified Glasgow Prognostic Score in small cell lung cancer: A meta-analysis. Xie Y; Li H; Hu Y Medicine (Baltimore); 2023 Nov; 102(45):e35962. PubMed ID: 37960803 [TBL] [Abstract][Full Text] [Related]
14. High pretreatment neutrophil-to-lymphocyte ratio as a predictor of poor survival prognosis in head and neck squamous cell carcinoma: Systematic review and meta-analysis. Yang L; Huang Y; Zhou L; Dai Y; Hu G Head Neck; 2019 May; 41(5):1525-1535. PubMed ID: 30597654 [TBL] [Abstract][Full Text] [Related]
15. Clinical utility of the modified Glasgow prognostic score in lung cancer: A meta-analysis. Jin J; Hu K; Zhou Y; Li W PLoS One; 2017; 12(9):e0184412. PubMed ID: 28886134 [TBL] [Abstract][Full Text] [Related]
16. The value of lymphocyte to monocyte ratio in the prognosis of head and neck squamous cell carcinoma: a meta-analysis. Wei D; Liu J; Ma J PeerJ; 2023; 11():e16014. PubMed ID: 37719125 [TBL] [Abstract][Full Text] [Related]
17. Prognostic Value of Cancer Stem Cell Markers in Head and Neck Squamous Cell Carcinoma: a Meta-analysis. Fan Z; Li M; Chen X; Wang J; Liang X; Wang H; Wang Z; Cheng B; Xia J Sci Rep; 2017 Feb; 7():43008. PubMed ID: 28220856 [TBL] [Abstract][Full Text] [Related]
18. Prognostic Value of Pretreatment Glasgow Prognostic Score/Modified Glasgow Prognostic Score in Ovarian Cancer: A Systematic Review and Meta-Analysis. Xu S; Song L; Liu X Nutr Cancer; 2022; 74(6):1968-1975. PubMed ID: 34549675 [TBL] [Abstract][Full Text] [Related]
19. Prognostic Value of Microvessel Density in Head and Neck Squamous Cell Carcinoma: A Meta-Analysis. Dong Y; Ma G; Liu Y; Lu S; Liu L Dis Markers; 2020; 2020():8842795. PubMed ID: 33062071 [TBL] [Abstract][Full Text] [Related]
20. Prognostic Value of the Glasgow Prognostic Score or Modified Glasgow Prognostic Score for Patients with Colorectal Cancer Receiving Various Treatments: a Systematic Review and Meta-Analysis. He L; Li H; Cai J; Chen L; Yao J; Zhang Y; Xu W; Geng L; Yang M; Chen P; Zheng J; Yang Y; Gong S Cell Physiol Biochem; 2018; 51(3):1237-1249. PubMed ID: 30481755 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]